BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9731108)

  • 1. Protective role of platelets in chronic (Balb/C) and acute (CBA/J) Plasmodium berghei murine malaria.
    Polack B; Delolme F; Peyron F
    Haemostasis; 1997; 27(6):278-85. PubMed ID: 9731108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopathology of thrombocytopenia in experimental malaria.
    Grau GE; Piguet PF; Gretener D; Vesin C; Lambert PH
    Immunology; 1988 Dec; 65(4):501-6. PubMed ID: 3065215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated IL-17 levels in semi-immune anaemic mice infected with Plasmodium berghei ANKA.
    Helegbe GK; Huy NT; Yanagi T; Shuaibu MN; Kikuchi M; Cherif MS; Hirayama K
    Malar J; 2018 Apr; 17(1):169. PubMed ID: 29665817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet depletion by anti-CD41 (alphaIIb) mAb injection early but not late in the course of disease protects against Plasmodium berghei pathogenesis by altering the levels of pathogenic cytokines.
    van der Heyde HC; Gramaglia I; Sun G; Woods C
    Blood; 2005 Mar; 105(5):1956-63. PubMed ID: 15494426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria.
    Grau GE; Fajardo LF; Piguet PF; Allet B; Lambert PH; Vassalli P
    Science; 1987 Sep; 237(4819):1210-2. PubMed ID: 3306918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haem oxygenase protects against thrombocytopaenia and malaria-associated lung injury.
    de Azevedo-Quintanilha IG; Medeiros-de-Moraes IM; Ferreira AC; Reis PA; Vieira-de-Abreu A; Campbell RA; Weyrich AS; Bozza PT; Zimmerman GA; Castro-Faria-Neto HC
    Malar J; 2020 Jul; 19(1):234. PubMed ID: 32611348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lambda-carrageenan treatment exacerbates the severity of cerebral malaria caused by Plasmodium berghei ANKA in BALB/c mice.
    Recuenco FC; Takano R; Chiba S; Sugi T; Takemae H; Murakoshi F; Ishiwa A; Inomata A; Horimoto T; Kobayashi Y; Horiuchi N; Kato K
    Malar J; 2014 Dec; 13():487. PubMed ID: 25495520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective immunity against Plasmodium berghei malaria after administration of interleukin-12.
    Normaznah Y; Halim AA; Outhayphone M; Zamri MR
    Malays J Pathol; 1999 Dec; 21(2):123-5. PubMed ID: 11068418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence and characterization of lymphocytotoxins in acute and chronic Plasmodium berghei malaria.
    Wangoo A; Ganguly NK; Mahajan RC
    Immunol Cell Biol; 1988 Feb; 66 ( Pt 1)():65-8. PubMed ID: 3286484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality and platelet depletion occur independently of fibrinogen consumption in murine models of tumour necrosis factor-mediated systemic inflammatory responses.
    Senaldi G; Piguet PF
    Cytokine; 1998 May; 10(5):382-9. PubMed ID: 9619377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet reactions in acute Plasmodium berghei infection in Swiss albino mice.
    Inyang AL; Okpako DT; Essien EM
    Haematologia (Budap); 1987; 20(2):101-8. PubMed ID: 3308658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-erythropoietin antibody levels and its association with anaemia in different strains of semi-immune mice infected with Plasmodium berghei ANKA.
    Helegbe GK; Huy NT; Yanagi T; Shuaibu MN; Kikuchi M; Cherif MS; Hirayama K
    Malar J; 2013 Aug; 12():296. PubMed ID: 23978045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease in platelet survival and total platelet sialic acid concentration in rats infected with Plasmodium bergei bergei.
    Inyang AL; Okpako D; Essien EM
    Afr J Med Med Sci; 1995 Mar; 24(1):41-6. PubMed ID: 7495199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible involvement of IFN-gamma in early mortality of Plasmodium berghei NK65-infected BALB/c mice after febrifugine treatment.
    Ishih A; Nagata T; Kobayashi F; Muregi FW; Ohori K; Miyase T
    Southeast Asian J Trop Med Public Health; 2008 Nov; 39(6):949-58. PubMed ID: 19062681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible involvement of platelets in Plasmodium yoelii nigeriensis malaria infection in mice.
    Oyekan AO; Onabanjo AO
    Haemostasis; 1991; 21(6):360-9. PubMed ID: 1823881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmodium berghei: cerebral malaria in CBA mice is not clearly related to plasma TNF levels or intensity of histopathological changes.
    Carvalho LJ; Lenzi HL; Pelajo-Machado M; Oliveira DN; Daniel-Ribeiro CT; Ferreira-da-Cruz MF
    Exp Parasitol; 2000 May; 95(1):1-7. PubMed ID: 10864512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VEGF and LPS synergistically silence inflammatory response to Plasmodium berghei infection and protect against cerebral malaria.
    Canavese M; Dottorini T; Crisanti A
    Pathog Glob Health; 2015 Sep; 109(6):255-65. PubMed ID: 26392042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet induction of the acute-phase response is protective in murine experimental cerebral malaria.
    Aggrey AA; Srivastava K; Ture S; Field DJ; Morrell CN
    J Immunol; 2013 May; 190(9):4685-91. PubMed ID: 23536632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF-induced microvascular pathology: active role for platelets and importance of the LFA-1/ICAM-1 interaction.
    Grau GE; Tacchini-Cottier F; Vesin C; Milon G; Lou JN; Piguet PF; Juillard P
    Eur Cytokine Netw; 1993; 4(6):415-9. PubMed ID: 7910490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of a Khaya ivorensis -Alstonia boonei extract combination as antimalarial prophylactic remedy.
    Tepongning RN; Lucantoni L; Nasuti CC; Dori GU; Yerbanga SR; Lupidi G; Marini C; Rossi G; Esposito F; Habluetzel A
    J Ethnopharmacol; 2011 Sep; 137(1):743-51. PubMed ID: 21742022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.